Taro Pharmaceuticals Inc, a subsidiary of Sun Pharmaceutical Industries Ltd has entered into an agreement with Canada’s Antibe Therapeutics Inc, to acquire 100 per cent in the company.
The decision to acquire 100% stake follows Sun Pharma subsidiary Taro Pharmaceuticals Inc entering into an agreement with Antibe. Sun Pharma said since the Ontario Court is overseeing the ...
Gujarat: TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited, has entered into an agreement with Antibe Therapeutics Inc., Canada, pursuant to which Sun Pharma has agreed ...
Sun Pharmaceutical has announced that its subsidiary, Taro Pharmaceuticals, has entered into an agreement to acquire a 100% stake in Antibe Therapeutics, a clinical-stage biotechnology company ...
In 2010, Sun Pharma acquired a controlling stake in Israel-based Taro Pharmaceuticals. In 2014, Sun Pharma acquired the Indian multinational pharmaceutical company Ranbaxy Laboratories.
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.0, a high ...
The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...
Guitar World on MSN4d
Chinese firm HSG acquires majority stake of Marshall in $1.1billion dealThe British amp giant and home audio success story will work closely with HongShan Capital Group to fuel future projects that ...
Canadian company, Aurinia Pharmaceuticals Inc. (AUPH) operates as a leading commercial-stage biopharmaceutical company. The company reported impressive financial results for the third quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback